Le Lézard
Classified in: Health
Subject: PER

Lianping Weng M.D., Joins The Oncology Institute of Hope and Innovation


CERRITOS, Calif., Jan. 24, 2020 /PRNewswire-PRWeb/ -- The Oncology Institute of Hope and Innovation welcomes Lianping Weng M.D., to their team of specialists.

Dr. Liangping Weng graduated with his Doctor of Medicine from Wannan Medical College in Wuhu, Anhui, China. He completed his residency in Internal Medicine from Mount Vernon Hospital in New York and his fellowship in Hematology/Oncology from Boston Medical Center in Boston Massachusetts. Dr. Weng has multiple publications and had participated in several research projects.

Dr. Liangping Weng is a dedicated physician who believes the most important aspect of cancer treatment is compassion and education. He strives to communicate efficiently with his patients and their loved ones. He enjoys getting to know his patients and their families and remains active in research and clinical studies.

 

SOURCE The Oncology Institute of Hope and Innovation


These press releases may also interest you

at 17:00
MosquitoMate, Inc., a leader in innovative mosquito control solutions, today announced that the United States Environmental Protection Agency (EPA) has granted registration for its revolutionary new product named "WB1 Males." This new mosquito...

at 17:00
Leading family safety and location app Life360, has today announced the rollout of new safety features and enhancements through a triple-tier membership structure, offering a spectrum of benefits. With 2 million Aussies already benefiting from the...

at 16:55
The Registered Nurses' Association of Ontario (RNAO) is welcoming 17 new health organizations to its world-renowned Best Practice Spotlight Organization® (BPSO®) program. These organizations, spanning all health-care sectors, join RNAO in its mission...

at 16:54
Dr. Ryan M. Jouett, DDS, LVIM, FICOI has become one of only 25 Master Dentists in the world as a graduate of the Las Vegas Institute for Advanced Dental Studies in Las Vegas, NV....

at 16:48
Endo, Inc. ("Endo" or the "Company"), a newly formed entity, today announced that it has successfully completed the previously announced acquisition of substantially all of the assets of Endo International plc ("EIP"), as contemplated under EIP's...

at 16:45
Solventum announced today that it will release carve-out financial results for the first quarter 2024 before the market opens on May 9, 2024. The earnings press release and accompanying materials will be available on the company's website at...



News published on and distributed by: